Vancouver Mayor: “InSite is crucial to this city”

It’s been a year since the application went to Health Canada for a second supervised injection site in Vancouver…so what’s happening?

The Conservative Government’s delayed approval of a second supervised injection site in Vancouver has left a lingering question – is the site going to disappear?

Vancouver Mayor Gregor Robertson is just one of many standing up and saying Insite needs to remain open.

“Harm reduction has proven to save lives so we absolutely have to keep this site open. InSite is crucial to this city until we have enough treatment to deal with the bigger problem.”

When asked about the future of InSite in Vancouver, and additional locations, Health Canada officials say they can’t talk about any matters that are still under review.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below